Cargando…
Ethical review of off-label drugs during the COVID-19 pandemic
High-quality scientific research is very important in attempting to effectively control the coronavirus disease 2019 (COVID-19) pandemic and ensure people’s health and safety. Chloroquine (CQ) and hydroxychloroquine (HCQ) have received much attention. This article comprehensively investigates the et...
Autores principales: | Li, Qiu-Yu, Lv, Ye, An, Zhuo-Yu, Dai, Ni-Ni, Hong, Xue, Zhang, Yu, Liang, Li-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258355/ https://www.ncbi.nlm.nih.gov/pubmed/35979109 http://dx.doi.org/10.12998/wjcc.v10.i17.5541 |
Ejemplares similares
-
Treatment strategies for gastric cancer during the COVID-19 pandemic
por: Kang, Wen-Zhe, et al.
Publicado: (2020) -
Establishing a tumour bank: banking, informatics and ethics
por: Qualman, S J, et al.
Publicado: (2004) -
MicroRNAs sound off
por: Weston, Michael D, et al.
Publicado: (2009) -
COVID-19 and off label use of drugs: an ethical viewpoint
por: Shojaei, Amirahmad, et al.
Publicado: (2020) -
The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs
por: Li, Yanbai, et al.
Publicado: (2023)